Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
High-yield production of immunogenic PV3 virus-like particle in yeast
AuthorsTian Chen; Qin Hong; Wenyu Han; Shuxia Wang; Cheng Lin; Jiaqi Yao; Chaoyang Lian; Qingwei Liu; Xiaoli Wang; Yanqiu Zhou; Yao Cong; Zhong Huang
AffiliationsShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China; Key Laboratory of RNA Science and Engineering, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China; Huasong (Shanghai) Biomedical Technology Co., LTD, Shanghai, China; Chongqing Huazhi Biopharmaceutical Co., LTD, Chongqing, China; Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China; Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China
Field-isolate recombinant tick-borne encephalitis viruses define reporter-stability guidelines for antiviral testing in flaviviruses
AuthorsBenoit Besson; Damien Mouton; Yamina Boukenadel; Theo Nass; Soonju Park; Nakyung Lee; Jianhui Li; David Shum; Redmond Smyth; Stefanie C. Becker; Carine Meignin; Sébastien Pfeffer
AffiliationsUniversité de Strasbourg, Architecture et Réactivité de l’ARN, Institut de Biologie Moléculaire et Cellulaire du CNRS, Strasbourg, France; Université de Strasbourg, M3i UPR9022, Institut de Biologie Moléculaire et Cellulaire du CNRS, France; Screening Platform Laboratory, Institut Pasteur Korea, Seongnam, South Korea; Research Group for Vector-Associated Biodiversity and Infection, University of Veterinary Medicine Hanover, Germany; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hanover, Germany
Class I capsid assembly modulators induce potent anti-HBV activity through direct viral suppression, innate immune activation and caspase-3-independent clearance of infected hepatocytes
AuthorsPu Wang; Xinchang Liu; Yong Xie; Yingjun Zhang; Baohua Gu; Jing Li; Yunfu Chen
AffiliationsSunshine Lake Pharma Co., Ltd., Dongguan, PR China; State Key Laboratory of Anti-Infective Drug Discovery and Development, Dongguan, PR China; Enterprise Key Laboratory of Anti-viral Drug Development for Guangdong Province, Dongguan, PR China
Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing
AuthorsHiteshi Vaidya; Manoj Kumar
AffiliationsVirology Unit, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39A, Chandigarh, 160036, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India; Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), Sahibzada Ajit Singh Nagar, Punjab, 160062, India
Dual-targeting engineered binding proteins block SARS-CoV-2 infection and complement activation
AuthorsFan Pu; Yiwan Guo; Xinni Pan; Xin Liu; Fan Yang
AffiliationsDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue #1277, Wuhan, 430022, China; Hubei Provincial Clinical Research Center for Precision Radiology & Interventional Medicine, Wuhan, 430022, China; Hubei Key Laboratory of Molecular Imaging, Wuhan, 430022, China; Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, China
HBVZ10 exhibits robust in vivo potency and synergizes with entecavir to drive efficient cccDNA elimination and HBsAg seroclearance
AuthorsBai-Hua Zhang; Yuanping Zhou; Yukun Wu; Stephen Horrigan; Laura Luckenbaugh; Jianming Hu; Fabien Zoulim; Yong-Yuan Zhang
AffiliationsVirology, HBVtech, Rockville, MD, USA; Department of Infectious Diseases & Gastroenterology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China; The YW Statistical Consulting, Ellicott City, MD, USA; Preclinical Department, Noble Life Sciences, Sykesville, MD, USA; Department of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA, USA; UMR PaThLiv U1350, INSERM, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Lyon Hepatology Institute, IHU EVEREST, Lyon, France
Oligomerized receptor binding domain blocks pan-sarbecovirus infection via enhanced avidity to host receptor
AuthorsJintao Zou; Lingyu Su; Jiansheng Lu; Haiming Jing; Jiahang Liu; Xiaoqiang Zeng; Menghan Ma; De Zhao; Jun Zhang; Zhang Zhang; Jinyong Zhang; Xiaopeng Zhang
AffiliationsNational Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, Beijing, 100071, China; Nanhu Laboratory, Jiaxing, Zhejiang, 314050, China; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Army Medical University, Chongqing, 400038, China
Antiviral profile of hepatitis B virus capsid assembly modulator ALG-001075, the parent of pevifoscorvir sodium
AuthorsYannick Debing; Hannah Vanrusselt; Cheng Liu; Jordi Verheyen; Lars Degrauwe; Dieudonné Buh Kum; Abel Acosta Sanchez; Adilson Carlos Francisco; Emma Wanicek; Hans J. Netter; Paul A. Ramsland; Andrew Leis; Shabih Shakeel; Jerome Deval; Michael Welch; Vladimir Serebryany; Antitsa Stoycheva; Leonid Beigelman; Pierre Raboisson; Sandrine Vendeville; Tse-I Lin; Lawrence M. Blatt; David B. Smith; Julian A. Symons; Lauriane Lecoq; Andreas Jekle
AffiliationsAligos Belgium BV, Leuven, Belgium; Aligos Therapeutics, Inc., South San Francisco, United States; Novalix, Leuven, Belgium; Molecular Microbiology and Structural Biochemistry (MMSB), UMR 5086 CNRS, Université de Lyon, France; School of Science, STEM College, RMIT University, Bundoora, Victoria, Australia; Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia; The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Melbourne, VIC, 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, VIC, 3052, Australia; Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC, 3052, Australia; ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Bio21 Molecular Science and 9 Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, VIC, 3052, Australia
Antiviral activity of nirmatrelvir against contemporary SARS-CoV-2 variants
AuthorsIrina Yurgelonis; Devendra K. Rai; Jonathan T. Lee; Zhenghui Li; Patricia McMonagle; Qingyi Yang; Weiqiang Li; Li Hao; Hussin A. Rothan; Brittany Washington; Elizabeth Titova; Mohammad Amin Behzadi; Alexey Gribenko; Kris M. White; Barry N. Kreiswirth; Yuao Zhu; Isabel Najera; Elaine Thomas; Rhonda D. Cardin; Charlotte M.N. Allerton; Annaliesa S. Anderson
AffiliationsAnti-Infectives, Pfizer Inc, Pearl River, NY, 10965, USA; Anti-Infectives, Pfizer Inc, Groton, CT, 06340, USA; Vaccines, Pfizer Inc., Pearl River, NY, 10965, USA; Internal Medicine, Pfizer Inc, Cambridge, MA, 02139, USA; Department of Microbiology, Icahn School of Medicine at Mt. Sinai, New York, NY, 10029, USA; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 07110, USA; Preclinical & Translational Sciences, Pfizer Inc, Cambridge, MA, 02139, USA; Anti-Infectives, Pfizer Inc, Cambridge, MA, 02139, USA; Internal Medicine, Pfizer Inc., London, UK
Construction of a suckling mouse model based on an EV-C96 clinical isolate and its application in drug screening and vaccine development
AuthorsJing Wang; Ying Qu; Yunyi He; Qiu Yang; Hanyu Zhu; Yongbei Chen; Xianlong Duan; Huanying Zheng; Shengjun Xiao; Qiliang Liu; Hongbo Liu
AffiliationsDepartment of Laboratory Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China; School of Pharmacy, Guilin Medical University, Guilin, Guangxi, China; Guangxi Key Laboratory of Multimodal Biomarkers and Precision Diagnosis, Guilin Medical University, Guilin, Guangxi, China; School of Laboratory Medicine and Biotechnology, Guilin Medical University, Guilin, Guangxi, China; Department of Laboratory Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China; Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, China; Department of Pathology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China; Key Laboratory of Medical Biotechnology and Translational Medicine, Education Department of Guangxi Zhuang Autonomous Region, Guilin, Guangxi, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
